ArticleCancers2026

Histologic Transformation in Follicular Lymphoma: Real-World Outcomes with Rituximab vs. Obinutuzumab-Based Combinations.

Dor Shpitzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.